123 related articles for article (PubMed ID: 9462614)
1. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.
González-Juanatey JR; Reino AP; García-Acuña JM; Varela Román A; Calvo Gómez C; Cabezas-Cerrato J
Am J Cardiol; 1998 Jan; 81(1):87-90. PubMed ID: 9462614
[TBL] [Abstract][Full Text] [Related]
2. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.
González-Juanatey JR; Pose Reino A; Román AV; García Acuña JM; Fernández López JA; Cerrato JC
Am J Cardiol; 1997 Feb; 79(3):373-6. PubMed ID: 9036764
[TBL] [Abstract][Full Text] [Related]
3. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).
Devereux RB; Dahlof B; Levy D; Pfeffer MA
Am J Cardiol; 1996 Jul; 78(1):61-5. PubMed ID: 8712120
[TBL] [Abstract][Full Text] [Related]
4. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
Dahlöf B; Hansson L
J Hypertens; 1992 Dec; 10(12):1513-24. PubMed ID: 1338083
[TBL] [Abstract][Full Text] [Related]
5. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
[TBL] [Abstract][Full Text] [Related]
6. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
[TBL] [Abstract][Full Text] [Related]
7. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
Oren S; Grossman E; Frohlich ED
Am J Cardiol; 1996 Jan; 77(1):93-6. PubMed ID: 8540468
[TBL] [Abstract][Full Text] [Related]
8. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
9. Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril.
Seara FJ; Juanatey JR; Sande JL; Veloso PR; Reino AP; Román AV; Cerrato JC; Peña MG
Ann Noninvasive Electrocardiol; 2003 Jan; 8(1):47-54. PubMed ID: 12848813
[TBL] [Abstract][Full Text] [Related]
10. Effects of enalapril and isradipine alone and in combination on blood pressure, renal function and echocardiographic parameters in mild hypertension.
De Rosa ML; Maddaluno G; Lionetti F; Di Palma U; Albanese L; Cardace P; Baiano A; Vigorito C
Int J Cardiol; 2000 Jun; 74(1):77-84. PubMed ID: 10854683
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of blood pressure control and left ventricular performance with small doses of enalapril.
González-Juanatey JR; Reino AP; García-Acuña JM; González-Juanatey C; Valdes L; de la Peña MG; Cabezas-Cerrato J
Am J Cardiol; 1999 Mar; 83(5):719-23. PubMed ID: 10080425
[TBL] [Abstract][Full Text] [Related]
12. Treatment of arterial hypertension in the elderly using enalapril.
Terranova R; Luca S; Calanna A
Minerva Med; 1999 Sep; 90(9):333-7. PubMed ID: 10719438
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
[TBL] [Abstract][Full Text] [Related]
14. Enalapril does not improve left ventricular diastolic dysfunction in young and mild hypertensives without concomitant hypertrophy.
Chang NC; Lai ZY; Wang TC
Am J Hypertens; 1996 Sep; 9(9):909-14. PubMed ID: 8879348
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
[TBL] [Abstract][Full Text] [Related]
16. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
[TBL] [Abstract][Full Text] [Related]
17. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
18. Treatment of diastolic dysfunction in hypertensive left ventricular hypertrophy.
Bella JN
Am J Hypertens; 2006 Sep; 19(9):937-8. PubMed ID: 16942936
[No Abstract] [Full Text] [Related]
19. Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension.
Ribstein J; Du Cailar G; Brouard R; Mimran A
Cardiology; 1993; 83 Suppl 1():57-63. PubMed ID: 7903217
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Gosse P; Roudaut R; Herrero G; Dallocchio M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
